We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results:1-10 of 5,634

By the Book: Hip Implant Claims Dismissed in Middle District of Florida
  • Reed Smith LLP
  • USA
  • September 21 2018

Recently, the Enviably Youthful Drug and Device Law Mother has been pushing us to plan a motherdaughter vacation. Her longtime companion no longer


FDA Commissioner discusses FDA’s efforts to prevent foodborne Cyclospora outbreaks
  • Keller and Heckman LLP
  • USA
  • September 20 2018

FDA Commissioner Scott Gottlieb has issued a press release in the aftermath of this summer’s Cyclospora (C. cayetanensis) outbreaks in fresh produce


OIG Recommends FDA Use Pre-submission Program to Evaluate Cybersecurity Risks
  • Dinsmore & Shohl LLP
  • USA
  • September 20 2018

In September 2018 the OIG published its report on the FDA’s review practices for medical devices with cybersecurity implications, referred to as


Want to have your cake and eat it? Reformulate!
  • Barker Brettell LLP
  • United Kingdom
  • September 20 2018

New regulations, recent government policies and consumer demand are putting pressure on the food and drink manufacturing industry to make healthier


FDA enforcement blitz combats underage use of cartridge-based E-Cigarettes and threatens to sack premarket review compliance policy and flavors
  • Keller and Heckman LLP
  • USA
  • September 19 2018

On September 12, 2018, in a self-described “blitz”, FDA announced a deluge of enforcement actions, including more than 1,300 warning letters and fines


Impending Tariffs on China to Impact Manufacturers of Dietary Supplements, OTC Drugs, Cosmetics
  • Morgan Lewis
  • USA, China
  • September 19 2018

Newly approved tariffs would impose 10 to eventual 25 tariffs on hundreds of chemical ingredients imported from China used for many FDA-regulated


More than a faux pas to use PHOs: The ban on partially hydrogenated oils (PHOs) comes into effect in Canada
  • DLA Piper
  • Canada
  • September 19 2018

On September 17, 2018, Health Canada’s ban on partially hydrogenated oils (“PHOs”) came into effect. It is now illegal for manufacturers to add PHOs


Philadelphia Mayor signs bill requiring sodium warning on menus
  • Keller and Heckman LLP
  • USA
  • September 18 2018

Philadelphia Mayor Jim Kenney signed legislation last Friday that requires chain food establishments to include warning labels on menus next to items


“Show-Me” the (Vegan) Meat! Missouri’s Foray into Meat Advertising Law
  • Michael Best & Friedrich LLP
  • USA
  • September 18 2018

“I come from a state that raises corn and cotton and cockleburs,” Missouri Congressman Willard Duncan Vandiver told a U.S. Navy banquet in 1899


FSMA update: FDA issues final Q&A guidance and attestation Forms for qualified facilities under HARPC Rules
  • Keller and Heckman LLP
  • USA
  • September 17 2018

On May 16, 2016 (81 FR 30219), FDA issued a draft guidance document intended to assist “qualified facilities” comply with modified requirements under